IRCT138708131431N1已完成3 期
Comparative Clinical Trial of Mebendazole, Praziquantel and Metronidazole in treatment of human Giardiasis
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 years 至 30 years（—）
- 性别
- All
入选标准
- •Patients with gastrointestinal complaints including diarrhea; weight loss; anorexia or fatigue and positive for Giardaisis. Exclusion criteria: Drug side effects; Immune deficiency; consumption of current antibiotic.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Mebendazole compared with secnidazole-adult giardiasis-Phase IIIGiardiasisRPCEC00000095Central Military Hospital Carlos J. Finlay110
已完成
3 期
A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric ParticipantsHelminth InfectionsNCT02034162Janssen Research & Development, LLC295
招募中
不适用
Effects of Mebendazole to Lenvatinib (drug) in liver cancerCTRI/2020/06/026240Institute of Liver and Biliary Sciences
已完成
4 期
Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican PopulationAmoebiasisHelminthiasisNCT02385058Janssen-Cilag Ltd.100
已完成
不适用
Comparative efficacy of albendazole and mebendazole against hookworm infection in LaosISRCTN29126001Swiss National Science Foundation (Switzerland)190